Drug Shortage Report for TEVA-ATENOLOL/CHLORTHALIDONE

Last updated on 2020-01-21 History
Report ID 952
Drug Identification Number 02302926
Brand name TEVA-ATENOLOL/CHLORTHALIDONE
Common or Proper name Atenolol Chlorthalidone
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) CHLORTHALIDONE ATENOLOL
Strength(s) 25MG 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C07CB
ATC description BETA BLOCKING AGENTS AND OTHER DIURETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2016-11-01
Actual start date 2016-10-17
Estimated end date
Actual end date 2019-09-30
Shortage status Resolved
Updated date 2020-01-21
Company comments Item Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-01-21 French Compare
v5 2020-01-21 English Compare
v4 2017-03-14 French Compare
v3 2017-03-14 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 6 of 6